Bicyclic peptide-based assay for uPA cancer biomarker

Biosens Bioelectron. 2022 Oct 1:213:114477. doi: 10.1016/j.bios.2022.114477. Epub 2022 Jun 16.

Abstract

The use of synthetic bioreceptors to develop biosensing platforms has been recently gaining momentum. This case study compares the performance of a biosensing platform for the human biomarker urokinase-type plasminogen activator (h-uPA) when using two bicyclic peptides (P1 and P2) with different affinities for the target protein. The bioreceptors P1 and P2 were immobilized on magnetic microbeads and tested within a sandwich-type affinity electrochemical assay. Apart from enabling h-uPA quantification at nanomolar levels (105.8 ng/mL for P1 and 32.5 ng/mL for P2), this case study showed the potential of synthetic bicyclic peptides applicability and how bioreceptor affinity can influence the performance of the final sensing platform.

Keywords: Biomarker; Biosensor; Peptides; Screen-printed electrodes; Synthetic bioreceptors; Urokinase-type plasminogen activator; uPA.

MeSH terms

  • Biomarkers, Tumor
  • Biosensing Techniques*
  • Humans
  • Neoplasms*
  • Peptides
  • Urokinase-Type Plasminogen Activator / metabolism

Substances

  • Biomarkers, Tumor
  • Peptides
  • Urokinase-Type Plasminogen Activator